Torrent Pharmaceuticals Ltd gets Form 483 with 5 observations for Indrad facility

The USFDA conducted a Pre-Approval Inspection (PAI) and a GMP inspection at TORRENT PHARMACEUTICALS LIMITED's manufacturing facility situated in Indrad, Gujarat from 03-Jun-24 to 12-Jun-24.

At the end of the inspection, the Company was issued a Form 483 with 5 (five) observations. There was no observation related to data integrity reported. We will respond to the USFDA within the prescribed time-frame and will work in close collaboration with the agency to address the observations at the earliest possible time.

Shares of Torrent Pharmaceuticals Limited was last trading in BSE at Rs. 2894.45 as compared to the previous close of Rs. 2850.60. The total number of shares traded during the day was 3609 in over 859 trades.

The stock hit an intraday high of Rs. 2919.95 and intraday low of 2856.20. The net turnover during the day was Rs. 10416800.00.

Source : Equity Bulls

Keywords

TorrentPharmaceuticals INE685A01028 PreApprovalInspection GMPInspection Form483 5Observations